Its misleading as it making assumptions that it will not be effective.
In all honesty if they have formulated the product based on PathAway results on other 130 viruses and bacteria, do you really think they will compromise the mixture by no having enough or changing the formula as so that it may not be effective product.
I get some here want to get more cheaper shares, but in the process you don't have to rubbish the product. If any assumptions are to be made it would be that it is effective on everything else before COVID-19.
COVID-19 TEST results SKN & HCT, page-387
-
- There are more pages in this discussion • 229 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SKN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.768M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $8.658K | 2.334M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 4244334 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 638999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| SKN (ASX) Chart |